WAY 161358
Latest Information Update: 18 Sep 2006
At a glance
- Originator Ligand Pharmaceuticals; Wyeth
- Class
- Mechanism of Action Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Menopausal syndrome; Pregnancy
Most Recent Events
- 18 Sep 2006 Discontinued - Preclinical for Menopausal syndrome in USA (PO)
- 18 Sep 2006 Discontinued - Preclinical for Pregnancy (Prevention) in USA (PO)
- 27 Mar 2002 American Home Products and its subsidiaries Wyeth-Ayerst and Wyeth Lederle are both now called Wyeth